WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 7'1901 Infant (under 12 months) mortality rate: 332
GDP / capita (US$): 12'5041 Child (under 5 years) mortality rate: 452

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 53'140  52'776  52'386  51'949  51'452  44'846  36'793  29'077 
Births 1'094  1'099  1'102  1'104  1'105  1'081  1'083  1'019 
Surviving infants 1'054  1'057  1'058  1'057  1'055  1'021  1'030  952 
Pop. less than 5 years 5'342  5'437  5'525  5'566  5'531  4'834  5'110  4'505 
Pop. less than 15 years 15'621  15'563  15'500  15'413  15'287  14'788  14'326  12'081 
Female 15-49 years 14'200  14'148  14'095  14'034  13'960  12'177  9'244  6'899 

Number of reported case

(Click for retrospective incidence data for South Africa)
Diphtheria 34  57 
Japanese encephalitis
Measles 66  25  32  92  12'499  1'459  10'624  19'193 
Mumps
Pertussis 230  116  181 
Polio* 112 
Rubella 10  103  2'298  3'266  541 
Rubella (CRS)
Tetanus (neonatal) 11  58  166 
Tetanus (total)** 11  117  288 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for South Africa)
Vaccine year result method % card seen                                                
BCG 2007  86     69  93  88  99*  94  90  99 
DTP1 2007  73     69  96  92  93  99*  99*  95 
DTP3 2007  63     69  95  90  93  97  91  96 
HepB_BD          95 
HepB3 2007  56     69  97  88  96  99  97  88 
Hib3 2007  45     69  95  90  93  97  91  88 
JapEnc         
MCV          91  87  99*  99  95  95 
MCV2          81  74  88  83  83  80 
PCV1          96  97  98  88 
PCV3          90  87  98  89  64 
Pol3 2007  67     69  95  90  93  97  99*  96 
Rota1          96  98  98  78 
Rota_last          94  89  99*  96  66 
Rubella1          83 
TT2plus          63  51  65 
PAB         
VAD1          50  43  97  87  96 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for South Africa)
BCG 84  84  78  74  89  57 
DTP1 69  70  77  77  85  89 
DTP3 65  68  72  66  73  72 
HepB3 65  73  76  74  73 
HepB_BD
Hib3 65  68  72  66  73 
MCV 66  79  78  74  72  79 
MCV2 53  67  62  62  57 
PAB 77  77  77  77  68 
PCV3 62  81  72  64 
Pol3 66  69  73  74  71  76 
Rota_last 64  78  72  66 

Number of districts in the country 52  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 50
From 80 to 89% 37
From 50 to 79% 13
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 6, 10, 14 weeks; 18 months; Yes From June 2015
DTaPHibIPV 6, 10, 14 weeks; 18 Months; Yes
HPV 9 years (2 doses); Yes
HepB 6, 10, 14 weeks; Yes and adults at contact, +1, +6 months
Influenza >6 months; >65 years; Children and adults with chronic illness, pregnant women, health care workers and other risk groups
Measles 9, 18 months; Yes
OPV birth; 6 weeks; Yes
Pneumo_conj 6, 14 weeks; 9 months; Yes
Rotavirus 6, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; Yes
Td 6, 12 years; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  Yes  No  Yes  Yes  Yes 
What years does the MYP cover? number NA    2013-2017      2010-2013  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number       52    48   

System performance

Total Nº districts in country number 52  52  52  52  52  52  52 
Nº districts with DTP3 coverage >=80% number 45  34  43  47  36  39 
% of districts with DTP3 coverage >=80% From 0 to 100% 87  65  83  90  69  75 
Nº districts with measles (MCV1) coverage >=95% number 12  44  26  19    20 
% of districts with MCV1 coverage >=95% From 0 to 100% 23  17  85  50  37    38 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.